Kidney Res Clin Pract.
2013 Jun;32(2):74-77.
Colchicine-induced myoneuropathy in a cyclosporine-treated renal transplant recipient
- Affiliations
-
- 1Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
- 2Division of Nephrology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. wooseong.huh@samsung.com
Abstract
- Colchicine is a relatively safe medication that is widely used for both prevention and treatment of gout attack. However, serious adverse events, includingmyoneuropathy and multiorgan failure, have been reported. We report a case of colchicine-induced myoneuropathy in a female kidney transplant recipient who had been taking cyclosporine. She developed gastrointestinal discomfort and paresthesia 5 days after the initiation of colchicine. She showed signs of myoneuropathy, and hepatic and renal injury. Colchicine toxicity was suspected, and colchicine was discontinued. Her symptoms and laboratory findings improved gradually. Literature was reviewed for previous reports of colchicine-induced myoneuropathy in solid organ transplant recipients.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Acute myopathy induced by colchicine in a cyclosporine-treated renal transplant recipient--a case report and review of the literature
- A Case of Colchicine-induced Acute Myopathy in a Renal Recipient
- Effect of Azithromycin in the Treatment of Cyclosporine-induced Gingival Hyperplasia in Renal Transplant Recipient
- Verruca Eradication Following Conversion to Sirolimus in a Renal Transplant Recipient after Longstanding Cyclosporine A Treatment
- Rhabdomyolysis in a Cyclosporine-treated Renal Transplant Recipient Who Received Atorvastatin as Replacement for Fluvastatin
